Scientific article
French

Prise en charge chirurgicale de l’hyperparathyroïdie primaire

Published inRevue médicale suisse, vol. 19, no. 831, p. 1162-1168
Publication date2023-06-14
Abstract

Primary hyperparathyroidism (PHPT) is characterized by hypercalcemia due to inappropriate parathyroid hormone (PTH) secretion mostly caused by a single adenoma. Clinical manifestations vary and include bone loss (osteopenia, osteoporosis), kidney stones, asthenia and psychiatric disorders. In 80 % of cases PHPT is asymptomatic. Secondary causes of elevated PTH such as renal insufficiency and/or vitamin D deficiency should be excluded, and 24-hour calciuria should be measured to rule out familial hyocalciuric hypercalcemia. Surgery requires radiological tests: a cervical ultrasound to exclude concomitant thyroid pathology and a functional examination (Sestamibi scintigraphy or F-choline PET scan). Management should be discussed in a multidisciplinary team. Treatment is surgical and can also be offered to asymptomatic patients.

Keywords
  • Humans
  • Hypercalcemia / diagnosis
  • Hypercalcemia / etiology
  • Hyperparathyroidism, Primary / diagnosis
  • Hyperparathyroidism, Primary / surgery
  • Asthenia
  • Choline
  • Kidney Calculi
Citation (ISO format)
DJAFARRIAN, Reza et al. Prise en charge chirurgicale de l’hyperparathyroïdie primaire. In: Revue médicale suisse, 2023, vol. 19, n° 831, p. 1162–1168. doi: 10.53738/REVMED.2023.19.831.1162
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 15/12/2024
Identifiers
Journal ISSN1660-9379
53views
0downloads

Technical informations

Creation22/06/2023 13:24:15
First validation25/03/2024 13:43:16
Update time25/03/2024 13:43:16
Status update25/03/2024 13:43:16
Last indexation01/11/2024 08:59:39
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack